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report
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Abstract 
Introduction: Turner syndrome is a genetic disorder in females and is the result of complete or partial loss of an 
X chromosome during fertilization. The missing X chromosome is originally either from the mother’s ovum or the 
father’s sperm cell. Approximately 45% of patients have the 45,X karyotype and the rest have other variants of Turner 
syndrome, which are either mosaicism patterns or structural abnormalities of the X chromosome. Here, we report a 
case of Turner syndrome that is the fifth case of Turner syndrome with balanced Robertsonian translocation of (13;14)
(q10;q10), and the sixth case with 44,X chromosomes, reported in the literature thus far.
Case presentation: A 10.3-year-old Persian girl was brought to our clinic by her parents, with the complaint of failure 
to thrive and short height. She had been examined and investigated by endocrinologists since the age of 4 years, 
but no definite diagnosis was made. At the time of presentation, she had been through three provocative growth 
hormone tests and had been on no medications for about a year. Her physical examination revealed mild retrognathia 
and micrognathia. Initially, she was started on somatropin treatment which, after 12 months, did not appropriately 
improve her height velocity. Therefore, a more thorough physical examination was performed, in which high arched 
palate and low posterior hairline were observed. There was also a difference between target height and patient 
height standard deviation scores. Karyotype study was requested, and Turner syndrome  was confirmed.
Conclusion: The diagnosis of this case was not straightforward, both because the somatic presentations were not 
obvious, and because the physicians had not looked for them when performing the physical examinations. This 
case report introduces a rare 44,X chromosome karyotype of Turner syndrome and highlights the value in using the 
difference between target height and patient height standard deviation scores as a simple and inexpensive tool for 
diagnosis of this syndrome.
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Introduction
Turner syndrome (TS) is a genetic disorder in females 
that is the result of complete or partial loss of an X 
chromosome during fertilization. It occurs in approxi-
mately one in 2500 female live births. The missing X 
chromosome is originally either from the mother’s ovum 
or the father’s sperm cell. Approximately 45% of patients 
have the 45,X karyotype [1–3] and the rest have other 
variants of TS, which are either mosaicism patterns or 
structural abnormalities of the X chromosome.
TS has a wide range of clinical symptoms. The most 
common symptoms are short stature and primary 
gonadal deficiency [1–3]. The patient may have somatic 
features such as high arched palate, low posterior hair-
line, and cervical web [1]. Other clinical features include 
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horseshoe kidney, coarctation of the aorta, diabetes, 
hypothyroidism, hypertension, hearing loss, osteoporo-
sis, bone fracture, and gastrointestinal problems. Skeletal 
anomalies such as cubitus valgus, Madelung deformity, 
and short fourth and fifth metacarpal and metatarsal 
bones are also seen [1–3]. Diagnosis of TS is based on 
suggestive clinical findings and karyotype analysis of 
peripheral blood, which reveals the numerical and/or 
structural abnormalities of the X chromosome.
This report presents a rare karyotype of TS. The 
patient’s diagnosis was not made until she was 10 years of 
age, as her clinical signs and symptoms were not obvious 
enough to be observed by endocrinologists. The delay 
in TS diagnosis could have been avoided if it had been 
considered as one of the differential diagnoses of short 
stature in girls with subtle signs on physical examination. 
The difference between patient height standard devia-
tion score (SDS) and target height SDS (TH SDS) is also a 
simple tool which can be used in the evaluation of short-
stature patients, and was a valuable guide in this rare 
case, allowing us to proceed with further evaluations.
Case presentation
A 10.3-year-old girl presented to the Children’s Walk-in 
Endocrinology Center (CWEC) in Bushehr, located on 
the northern shore of the Persian Gulf, accompanied by 
her parents, with the chief complaint of short stature and 
failure to thrive. She was the first child of Persian non-
consanguineous parents from southern Iran. Her father 
was an engineer and her mother was a teacher. The fam-
ily was of high socioeconomic and normal psychosocial 
status. The second child of the family was a 4.5-year-
old girl with normal growth and development who had 
not required any specific medical attention. The patient 
was the product of a normal vaginal delivery at a gesta-
tional age of 32 weeks, with a birth weight of 2400 g. Her 
birth length and head circumference were 41 and 30 cm, 
respectively. She was conceived when her mother was 26 
and her father 32  years old. According to our patient’s 
infantile weight and height growth chart, she was in the 
third percentile in the first 4  months, and continued to 
ascend in the third percentile for age and sex with nor-
mal height velocity up to the age of 2  years. Sufficient 
information about her growth velocity was not available 
beyond that age.
She had been examined intermittently by endocrinol-
ogists between the ages of 4 and 9 years due to failure 
to thrive and short stature. Three provocative growth 
hormone (GH) tests were performed during that time. 
The first was conducted with levodopa provocation 
when she was 4.9 years old. The second and third tests 
were carried out with clonidine provocation (5 mcg/kg) 
when she was 7.8 and 9.1  years old, respectively. The 
results of GH provocation tests were 5.11 ng/mL (at the 
age of 4.9  years), 10.5  ng/mL (at the age of 7.8  years), 
and 6.99  ng/mL (at the age of 9.1  years). Two of the 
tests showed no response, and therefore GH replace-
ment therapy [somatropin, NordiLet pen 5 mg/1.5 mL 
(35  mcg/kg/day)] was initiated and delivered via sub-
cutaneous injections, nightly, six times per week. Eight 
months later, the treatment was ceased because the 
patient had not gained acceptable growth velocity and 
height. In addition to the above treatment, she was on 
oral supplements including zinc 5 mg daily and multi-
vitamins, but her parents were not aware of the exact 
dosage and type of vitamins. Other pathologies which 
were initially checked in this case were thyroid function 
tests, screening for celiac disease, and kidney and liver 
function tests, which were all at normal levels (Table 1). 
Plain X-ray of her left hand and wrist did not detect 
any abnormalities, and the bone age, according to 
Greulich and Pyle, was 7 years for a chronological age 
of 8.2  years. There was no other detailed information 
about her growth velocity and management.
By the time the patient presented to CWEC, she had 
not been taking any prescribed or over-the-counter 
medications for about a year. She was a fifth grade stu-
dent and a bit behind her class. She was short and slim, 
with height of 118 cm. Height standard deviation score 
(SDS) was −3.3 and weight was 19  kg. Her mother’s 
height was 159.5 cm and father’s height was 167cm.
Mid-parental height (MPH)  =  (mother’s 
height + father’s height/2) − 6.5 cm = 156.75 cm
Target height (TH) =  161.25 cm (calculated by Tan-
ner’s method with an additional correction for secular 
trend = MPH + 4.5 cm) [4].
TH SDS was −0.3. The difference between TH SDS 
and patient height SDS was –3 SD.
Table 1 Laboratory findings before  presenting 
to Children’s Walk-in Endocrinology Center
WBC white blood cells, RBC red blood cells, TSH thyroid-stimulating hormone, BS 
blood sugar, TTG tissue transglutaminase, IgA immunoglobulin A
Test (normal range) Age 4.9 years Age 7.8 years
WBC (4500–15,000 cells/µL) 8900 cells/µL 9100 cells/µL
RBC (4–5.4 × 106/µL) 4.49 × 106/µL 5.16 × 106/µL
Hemoglobin (> 11.5 g/dL) 12.6 g/dL 13.6 g/dL
Mean corpuscular volume (> 77 fL) 81.7 fL 75.6 fL
Platelet count (150,000–
450,000 cells/µL)
292,000 cells/µL 337,000 cells/µL
TSH (0.6–5.5 µIU/mL) – 1.4 µIU/mL
Thyroxine (6–13.8 µg/dL) – 8.3 µg/dL
BS (55–140 mg/dL) – 84 mg/dL
TTG IgA antibody (< 12 IU/L) 0.7 IU/L –
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On the first consultation, the vital signs were normal 
(blood pressure 90/60  mmHg, heart rate 98 beats per 
minute, and temperature 36.8  °C). Physical examina-
tion indicated mild  retrognathia and micrognathia. The 
parents claimed  that the face was similar to   that of her 
paternal grandmother. She had no signs of puberty. Neu-
rological evaluation and other aspects of physical exami-
nation including chest, heart, abdomen, extremities, and 
genitalia were normal.
Initially, we took into account her being small for ges-
tational age (SGA) at birth (low birth weight and height 
SDS  < −1.88 after the age of 2  years [4]), being una-
ble to reach the normal growth chart since the age of 
4  years, and having had two unresponsive provocative 
GH tests, and diagnosed her with SGA without catch-
up growth. She was started on GH [somatropin (Nor-
diLet pen 5  mg/1.5  mL) 35  mcg/kg/day, subcutaneous 
injections seven nights per week]. She was also put on 
a regimen of multivitamins (Nature Made Multivitamin 
Complete tablet), one tablet six times per week. Kid-
ney, liver, and thyroid function, complete blood count, 
biochemistry, urinalysis, and celiac disease studies 
were again requested and were all with normal ranges 
(Table 2). One year after being on this treatment cock-
tail, the height velocity had not improved according to 
our expectations. Height SDS was −3.4, and increment 
in height SDS was −0.1.
At this time, we performed another physical examina-
tion and found that the patient had a high arched pal-
ate and low posterior hairline. She had no other somatic 
signs of TS including short neck, scoliosis, cubitus valgus, 
short fourth metacarpal or metatarsal bone, or Madelung 
deformity. The next and final step of our investigation 
was to request karyotype screening, which confirmed a 
diagnosis of TS, even though her karyotype was not typi-
cal of TS.
Twenty-one metaphase spreads were studied based on 
the trypsin-Giemsa G-band (GTG) technique at 400–
550-band resolution. Chromosome analysis revealed an 
abnormal female chromosome complement in all cells 
examined with a single X chromosome and a balanced 
Robertsonian translocation between the long arms of 
chromosomes 13 and 14. The result showed TS with 
44,X,der(13;14)(q10;q10) karyotype (Fig. 1).
Table 2 Findings of laboratory tests performed at Children’s Walk-in Endocrinology Center
CBC complete blood count, WBC white blood cells, RBC red blood cells, Hb hemoglobin, MCV mean corpuscular volume, BUN blood urea nitrogen, BS blood sugar, 
AST aspartate aminotransferase, ALT alanine aminotransferase, TSH thyroid-stimulating hormone, IgA immunoglobulin A, ACTH adrenocorticotropic, IGF-1 insulin-like 
growth factor 1, SG specific gravity
Test (normal range) Age: 10.3 years Age: 12.5 years Age: 14 years
CBC
 WBC (4500–15,000/µL) 7470/µL 7380/µL 7700/µL
 RBC (4–5.4 × 106/µL) 5.24 × 106/µL 4.97 × 106/µL 4.74 × 106/µL
 Hb (> 11.5 g/dL) 13.9 g/dL 14.1 g/dL 13.7 g/dL
 MCV (> 77 fL) 79.8 fL 80.7 fL 82.7 fL
 Platelet count (150,000–450,000 cells/µL) 214,000 cells/µL 151,000 cells/µL 195,000 cells/µL
BUN (6–24 mg/dL) 8.2 mg/dL
Creatinine (0.3–0.7 mg/dL) 0.4 mg/dL
Sodium (135–145 mEq/L) 138 mEq/L
Potassium (3.5–5.5 mEq/L) 3.9 mEq/L
BS (55–140 mg/dL) 84 mg/dL 86 mg/dL 87 mg/dL
AST (< 35 IU/L) 26 IU/L 23 IU/L
ALT (< 35 IU/L) 20 IU/L 18 IU/L
TSH (0.6–5.5 µIU/mL) 3.29 µIU/mL 2.93 µIU/mL 3 µIU/mL
Total thyroxine (6–13.8 µg/dL) 8.62 µg/dL 6 µg/dL 8.5 µg/dL
Calcium (8.8–10.5 mg/dL) 9.6 mg/dL
Phosphor (3.5–6.4 mg/dL) 5.9 mg/dL
Anti-tissue transglutaminase IgA (< 12 U/mL) 9.2 U/mL 2.5 U/mL
Alkaline phosphatase (180–1200 IU/L) 402 IU/L
ACTH (7.2–63.6 pg/mL) 52.28 pg/mL
Cortisol (171–536 nmol/L) 978.9 nmol/L
IGF-1 (87.4–399 ng/mL) 182.49 ng/mL 680.4 ng/mL 302 ng/mL
Urinalysis WBC = 0, RBC = 0, SG = 1.018
Stool exam WBC = 0, RBC = 0, Parasite = negative
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Karyotype studies of the parents and the only sib-
ling (the patient’s 6-year-old sister) were requested. 
Karyotype analysis of the mother and sister were nor-
mal (46,XX), but the father’s analysis showed a bal-
anced Robertsonian translocation between the long 
arms of chromosomes 13 and 14, similar to the patient’s 
[45,XY,der(13;14)(q10;q10)] (Fig. 2). It appeared that the 
balanced translocation was transmitted from the father. 
We did not determine whether the origin of the single X 
chromosome was paternal or maternal.
When the TS diagnosis was confirmed at the age of 
11.9  years, we increased the dose of GH to 50  mcg/kg/
day, and oral oxandrolone (0.04  mg/kg/nightly) was 
added to the treatment. Cardiac and renal evaluations 
were normal. Her annual blood pressure measurements 
were within the normal range (on average 85/60 mmHg). 
Abdominal sonography demonstrated a rudimentary 
uterus, and ovaries were not visible. The patient was 
reviewed every 6 to 12  months, and her height, weight, 
and growth velocity were measured, in addition to gen-
eral physical examination and assessment of the recent 
blood results. In the first 15 months of her treatment and 
follow-up,  her height increased 6 cm (Table 3).
The increase in height SDS was −0.5  SD, which was 
not sufficient. Once again, we checked thyroid function 
and serum anti-tissue transglutaminase (TTG) immuno-
globulin A (IgA), and performed fecal tests to detect any 
evidence of autoimmune thyroid, celiac, or inflammatory 
bowel diseases. All the results were within the normal 
range (Table 2). By then, she was 14 years old, with height 
of 137 cm (SDS = −3.6) and weight of 31 kg. The height 
increment in the second year of treatment was +0.3 SD 
(Table 3).
This young girl is still on GH (NordiLet pen 50 mcg/
kg/day) and oxandrolone treatment. We have not yet 
started her on estrogen replacement therapy, as the 
Fig. 1: Karyotype of the patient which shows Turner syndrome with 44X,der(13;14)(q10; q10)
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ultimate height increase was the first concern, but it 
will be considered in our next step of treatment. The 
last bone age measurement, according to Greulich 
and Pyle, was 11.9  years, with chronological age of 
13.5 years.
If the diagnosis had been made earlier and the GH 
had started with a higher dose from the beginning, her 
height would be predicted to be taller [5].
Patient perspective
When the condition was discussed with her parents, 
they became anxious and were in denial at first. Later 
on, they accepted the situation, especially when the 
syndrome characteristics were explained to them in 
full detail. They were very cooperative, and encour-
aged their daughter to attentively take the medications. 
However, the parents decided to not inform the patient 
of the exact diagnosis, as they were worried it might 
affect her mental health. Although both the patient 
and her parents were unhappy and disappointed that it 
took more than a decade for the diagnosis to be clari-
fied, despite the fact that they were frequently seeking 
medical attention, they acknowledged that TS is not a 
common condition, and were there higher awareness of 
the symptoms and diagnosis of this syndrome among 
physicians, particularly endocrinologists, it could have 
been managed earlier and the outcome would be more 
acceptable.
Fig. 2: Karyotype of the father: balanced Robertsonian translocation between the long arms of chromosomes 13 and 14 (45,XY,der (13;14)(q10; 
q10)




Height (cm) Height SDS Delta height SDS
11.75 124 −3.4
12.4 127.5 −3.5
13 130 −3.9 −0.5 SD
13.5 133.5 −3.8
14 137 −3.6 +0.3 SD
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Discussion
Our patient is the fifth case of TS reported in the litera-
ture with balanced Robertsonian translocation of (13;14)
(q10;q10), and the sixth case with 44,X chromosomes. In 
her first presentation to our center, at the age of 10 years, 
the patient was a severely short girl with some somatic 
signs of TS, which unfortunately had not been diagnosed 
until then. In this scenario, the limited knowledge of 
medical practitioners of possible etiologies of failure to 
thrive and short stature in young girls was the main rea-
son for the delayed diagnosis. Therefore, this highlights 
the importance of expanding our knowledge of differ-
ential diagnoses and paying attention to the difference 
between patient height standard deviation score (SDS) 
and target height SDS, and any subtle sign on physical 
examination. In addition to the above, we also recom-
mend considering TS in every short-stature girl with a 
diagnosis of SGA without catch-up growth or growth 
hormone deficiency (GHD) who has not reached normal 
growth chart height with GH treatment.
Torun et al. emphasized that TS should be considered 
in every short girl as the etiology of short stature. Even 
if no phenotypic signs consistent with TS are detected, 
karyotype analyses should be carried out [6]. In our case, 
if therapy had been initiated before the patient had devi-
ated significantly from the normal growth curve, she 
would have had a greater potential for catch-up growth, 
and greater height potential would have remained. Dur-
ing the initial consultations, diagnosis of TS was ignored 
for the following reasons:
1. The patient was born with low birth weight and had 
not gained normal growth after the age of 4 years.
2. She was frequently managed by two senior endocri-
nologists, whose opinion and diagnosis were relied 
on by other physicians.
3. She had two unresponsive GH provocative tests 
which, in addition to her severe short stature, made 
the likelihood of GHD very high.
Clinical signs in favor of TS in our case are the height 
SDS greater than two standard deviations below TH SDS 
[7] and some somatic signs (high arched palate, pos-
terior hairline), but it was the karyotyping tests which 
confirmed the diagnosis of TS. Although the majority of 
TS cases have 45X or mosaicism variant karyotypes, our 
case has 44 chromosomes and also a balanced transloca-
tion of a pair of somatic chromosomes (13;14).
There have been only four case reports of TS with 44 
chromosomes and this type of translocation in the litera-
ture. The first case was reported in 1985 by Salamanca. 
The patient had 44,X,der(13;14) translocation, the same 
as our patient. The (13;14) translocation was maternally 
inherited but the study did not investigate the paternal 
origin of X chromosome non-disjunction [8].
The second was reported by Laszlo et al., which was a 
case of 44,X streak gonad syndrome with balanced Rob-
ertsonian translocation of (13;14) whose mother carried 
the translocation [9].
The third was a case of TS reported by Krajinovic et 
al. in 1994. The patient was a 16-year-old girl with short 
stature, amenorrhea, and phenotypic characteristics of 
TS. The karyotype was 44,X,t(13q;14q). Similar to our 
case, the translocation was inherited from her father. Her 
mother and sister had normal female karyotypes. The X 
chromosome was also paternally inherited [10].
The fourth case was reported by da Silva et al. in 2006. 
The patient was a 5-year-old girl with short stature and 
facial dysmorphia. Chromosome analysis showed X 
monosomy and balanced Robertsonian translocation 
between chromosomes 13 and 14 [44,X,der(13;14)(q10; 
q10)], which is similar to our patient. However, in da 
Silva’s case, the karyotype of the father was normal, and 
it was the mother who carried a balanced translocation. 
The origin of the patient’s X chromosome was paternal, 
and chromosomes 13 and 14 showed biparental inherit-
ance [11].
The last reported case of TS with 44 chromosomes was 
an 11-year-old girl with short stature and clinical signs of 
TS, reported by Mariño et al. Her balanced translocation 
was different from the other reported cases of TS and 44 
chromosomes. This patient’s karyotype showed X mono-
somy and Robertsonian translocation between chromo-
somes 15 and 22 [44,X,der(15;22)(q10; q10)]. Paternal 
karyotyping was not performed [12].
Conclusion
Our case is the fifth case of TS with balanced Robertso-
nian translocation of (13;14)(q10;q10) reported in the 
literature, and the sixth reported case with 44,X chromo-
somes in patients with TS. Poor attention to the clinical 
symptoms of TS in a short girl and failing to consider the 
difference between patient height SDS and target height 
SDS resulted in a delay in the diagnosis of this case. It is 
crucial that physicians, and endocrinologists in particu-
lar, consider ruling out TS in every short girl even if they 
have no other somatic signs of TS, especially if the diag-
nosis is in doubt or the response to the usual treatment 
is not acceptable. This case also points out that the first 
examination should always be as thorough as possible, 
and physicians should not rely solely on the diagnosis 
and investigations previously performed. Furthermore, 
this case report illustrates the value in the measurement 
of the difference between target height SDS and patient 
height SDS as a simple and inexpensive tool for the diag-
nosis of TS, highlighting the rare karyotype forms.
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